COMMUNIQUÉ DE PRESSE

par Marinomed Biotech AG

EQS-Adhoc: Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange. 

+++ End of ad-hoc announcement +++ 


End of Inside Information

14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com


Language:English
Company:Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Phone:+43 2262 90300
E-mail:office@marinomed.com
Internet:www.marinomed.com
ISIN:ATMARINOMED6
WKN:A2N9MM
Listed:Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market)
EQS News ID:1968247

 
End of AnnouncementEQS News Service

1968247  14-Aug-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1968247&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
Voir toutes les actualités de Marinomed Biotech AG